TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 51.70
+0.90 (1.77%)
Apr 20, 2026, 1:14 PM CST
TSH Biopharm Corporation Revenue
In the year 2025, TSH Biopharm Corporation had annual revenue of 1.34B TWD with 19.79% growth. TSH Biopharm Corporation had revenue of 357.53M in the quarter ending December 31, 2025, with 22.82% growth.
Revenue
1.34B
Revenue Growth
+19.79%
P/S Ratio
1.46
Revenue / Employee
17.59M
Employees
76
Market Cap
1.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.34B | 220.81M | 19.79% |
| Dec 31, 2024 | 1.12B | 304.80M | 37.59% |
| Dec 31, 2023 | 810.92M | 69.85M | 9.43% |
| Dec 31, 2022 | 741.07M | 327.58M | 79.23% |
| Dec 31, 2021 | 413.48M | -34.38M | -7.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maywufa Company | 1.58B |
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| Allied Biotech | 849.51M |
| DV Biomed | 794.18M |
| Winston Medical Supply | 700.07M |
| GeneFerm Biotechnology | 677.10M |
| Johnson Chemical Pharmaceutical Works | 569.77M |